Breast Cancer: Recurrent Genomic Alterations: Difference between revisions

[unchecked revision][unchecked revision]
No edit summary
No edit summary
Line 248: Line 248:
|20301425; 29368626; 30062102; 30504931; 33471991
|20301425; 29368626; 30062102; 30504931; 33471991
|-
|-
|''C19MC''
|C19MC
|3
|3
|Gain of function
|Gain of function
Line 1,405: Line 1,405:
|TOP2A breast
|TOP2A breast
|amplification, sequence variants
|amplification, sequence variants
|Therapy: responsiveness to anthracycline inhibitors
|Therapy: responsiveness to anthracycline inhibitors. Prognosis: increased TOP2A expression is an adverse prognostic indicator.
|22578285; 32140564; 20038724; 21917518
|22578285; 32140564; 20038724; 21917518; 32780321; 35297009
|-
|-
|''TP53''
|''TP53''
Line 1,431: Line 1,431:
|3
|3
|Gain of function
|Gain of function
|601622
|[https://omim.org/entry/601622 601622]
|TWIST1
|[https://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=TWIST1 TWIST1]
|TWIST1 breast
|[https://www.cbioportal.org/results/oncoprint?cancer_study_list=acbc_mskcc_2015%2Cbreast_cptac_gdc%2Cbrca_hta9_htan_2022%2Cbrca_metabric%2Cbreast_msk_2025%2Cbreast_msk_2018%2Cbrca_pareja_msk_2020%2Cbrca_mskcc_2019%2Cbreast_alpelisib_2020%2Cbrca_smc_2018%2Cbrca_bccrc_xenograft_2014%2Cbfn_duke_nus_2015%2Cbrca_bccrc%2Cbrca_broad%2Cbrca_sanger%2Cbrca_tcga_pub2015%2Cbrca_tcga%2Cbrca_tcga_pub%2Cbrca_tcga_pan_can_atlas_2018%2Cbrca_tcga_gdc%2Cbrca_jup_msk_2020%2Cbrca_mapk_hp_msk_2021%2Cmbc_msk_2021%2Cbrca_aurora_2023%2Cbrca_dfci_2020%2Cbrca_igr_2015%2Cbreast_ink4_msk_2021%2Cilc_msk_2023%2Cbrca_cptac_2020%2Cbrca_mbcproject_wagle_2017%2Cbrca_mbcproject_2022%2Cbrca_fuscc_2020&Z_SCORE_THRESHOLD=2.0&RPPA_SCORE_THRESHOLD=2.0&profileFilter=mutations%2Cstructural_variants%2Ccna%2Cgistic%2Clog2CNA&case_set_id=all&gene_list=TWIST1&geneset_list=%20&tab_index=tab_visualize&Action=Submit TWIST1 breast]
|amplification, altered expression
|amplification, altered expression
|Diseases: breast cancer invasion and metastasis, basal-like breast cancer
|Diseases: breast cancer invasion and metastasis, basal-like breast cancer
|17437280; 19373776; 15131050; 27412325; 29073077; 27524420; 38963044; 35843065; 38003483
|[https://pubmed.ncbi.nlm.nih.gov/17437280/ 17437280]; [https://pubmed.ncbi.nlm.nih.gov/19373776/ 19373776]; [https://pubmed.ncbi.nlm.nih.gov/15131050/ 15131050]; [https://pubmed.ncbi.nlm.nih.gov/27412325/ 27412325]; [https://pubmed.ncbi.nlm.nih.gov/29073077/ 29073077]; [https://pubmed.ncbi.nlm.nih.gov/27524420/ 27524420]; [https://pubmed.ncbi.nlm.nih.gov/38963044/ 38963044]; [https://pubmed.ncbi.nlm.nih.gov/35843065/ 35843065]; [https://pubmed.ncbi.nlm.nih.gov/38003483/ 38003483]
|-
|-
|''ZNF217''
|''ZNF217''